ArticleBMC urology2026
Dwell time of percutaneous nephrostomies in pregnancy - what is the optimal exchange interval?
Article in BMC urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIf procedural intervention is indicated, options for management of obstructive uropathy in pregnancy include ureteric stenting, primary ureteroscopy (for calculi), or percutaneous nephrostomy. Early encrustation/blockage of nephrostomy tubes in pregnancy has been described, due to glomerular hyperfiltration/hypercalcuria. Some authors describe shorter exchange intervals (i.e. 3-weekly), while AUA guidelines recommend exchange 4–6 weekly. This study aims to evaluate outcomes of nephrostomy insertion during pregnancy in a tertiary centre in Melbourne, Australia.
methodsSeventeen patients underwent percutaneous nephrostomy insertion during pregnancy from 2013 to 2023, in a tertiary centre in Melbourne, Australia. Data collected retrospectively included indication for nephrostomy, radiation exposure, dwell time, blockage/dislodgement rates, urological and obstetric outcomes.
resultsOf 17 pregnant patients, indication for nephrostomy included ureteric calculus (n = 13), transplant hydronephrosis (n = 1), ureteric clot obstruction (n = 1), obstructive cervical malignancy (n = 1), and infected PUJO (n = 1). Mean age was 32.5 years (SD 5.7 years), whilst mean gestation stage was 25.0 weeks (SD 9.4 weeks). Regarding radiation exposure – mean DAP was 219.7 uGym2, mean air kerma 33.6 mGy, and mean fluoroscopy time 1.5 min. Mean nephrostomy dwell time was 37.45 days/5.35 weeks (SD 25.1 days), while median dwell time was 31 days (IQR 21.5–45 days). There were no peri-procedural urological or major obstetric complications.
conclusionIn our pregnant cohort (albeit small), mean nephrostomy dwell time was notably greater than previously described (5.35 weeks in our cohort vs. ~ 3 weeks in the literature). This finding aligns with AUA guidelines for nephrostomy exchange 4–6 weekly in pregnancy. Larger volume prospective data is required to establish appropriate exchange intervals for nephrostomies in pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.